当前位置: X-MOL 学术Channels › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Calmodulin binds to the N-terminal domain of the cardiac sodium channel Nav1.5.
Channels ( IF 3.3 ) Pub Date : 2020-08-20 , DOI: 10.1080/19336950.2020.1805999
Zizun Wang 1 , Sarah H Vermij 1 , Valentin Sottas 1, 2 , Anna Shestak 3 , Daniela Ross-Kaschitza 1 , Elena V Zaklyazminskaya 3 , Andy Hudmon 4 , Geoffrey S Pitt 5 , Jean-Sébastien Rougier 1 , Hugues Abriel 1
Affiliation  

ABSTRACT

The cardiac voltage-gated sodium channel Nav1.5 conducts the rapid inward sodium current crucial for cardiomyocyte excitability. Loss-of-function mutations in its gene SCN5A are linked to cardiac arrhythmias such as Brugada Syndrome (BrS). Several BrS-associated mutations in the Nav1.5 N-terminal domain (NTD) exert a dominant-negative effect (DNE) on wild-type channel function, for which mechanisms remain poorly understood. We aim to contribute to the understanding of BrS pathophysiology by characterizing three mutations in the Nav1.5 NTD: Y87C–here newly identified–, R104W, and R121W. In addition, we hypothesize that the calcium sensor protein calmodulin is a new NTD binding partner. Recordings of whole-cell sodium currents in TsA-201 cells expressing WT and variant Nav1.5 showed that Y87C and R104W but not R121W exert a DNE on WT channels. Biotinylation assays revealed reduction in fully glycosylated Nav1.5 at the cell surface and in whole-cell lysates. Localization of Nav1.5 WT channel with the ER did not change in the presence of variants, as shown by transfected and stained rat neonatal cardiomyocytes. We demonstrated that calmodulin binds the Nav1.5 NTD using in silico modeling, SPOTS, pull-down, and proximity ligation assays. Calmodulin binding to the R121W variant and to a Nav1.5 construct missing residues 80–105, a predicted calmodulin-binding site, is impaired. In conclusion, we describe the new natural BrS Nav1.5 variant Y87C and present first evidence that calmodulin binds to the Nav1.5 NTD, which seems to be a determinant for the DNE.



中文翻译:

钙调蛋白与心脏钠通道 Nav1.5 的 N 末端结构域结合。

摘要

心脏电压门控钠通道 Na v 1.5 传导对心肌细胞兴奋性至关重要的快速内向钠电流。其基因SCN5A的功能丧失突变与心律失常(如布鲁格达综合征 (BrS))有关。Na v 1.5 N 末端结构域 (NTD)中的几个 BrS 相关突变对野生型通道功能产生显性负效应 (DNE),但其机制仍知之甚少。我们的目标是通过表征 Na v 1.5 NTD中的三个突变来促进对 BrS 病理生理学的理解:Y87C(此处新鉴定)、R104W 和 R121W。此外,我们假设钙传感器蛋白钙调蛋白是一种新的 NTD 结合伴侣。表达 WT 和变体 Na v 1.5的 TsA-201 细胞中全细胞钠电流的记录表明,Y87C 和 R104W 但 R121W 在 WT 通道上发挥 DNE。生物素化测定显示细胞表面和全细胞裂解物中完全糖基化的 Na v 1.5减少。Na v 1.5 WT 通道与 ER 的定位在存在变异的情况下没有改变,如转染和染色的大鼠新生心肌细胞所示。我们使用计算机建模、SPOTS、pull-down 和邻位连接测定证明了钙调蛋白与 Na v 1.5 NTD结合。钙调蛋白与 R121W 变体和 Na v 1.5 构建体的结合受损,其中缺失残基 80-105(预测的钙调蛋白结合位点)。总之,我们描述了新的天然 BrS Na v 1.5 变体 Y87C,并提出了钙调蛋白与 Na v 1.5 NTD 结合的第一个证据,这似乎是 DNE 的决定因素。

更新日期:2020-08-20
down
wechat
bug